PROPHASE LABS INC. - COMMON STOCK

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9

02 May 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

25 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Unveils Project ZenQ-AI

16 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

10 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 Apr 2024 21:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

15 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

08 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

20 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

14 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics

30 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

23 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024

04 Jan 2024 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

09 Nov 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

02 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

17 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs to Present at The ThinkEquity Conference

12 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

10 Aug 2023 10:40:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023

10 Aug 2023 08:00:02 By Nasdaq GlobeNewswire

ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound

03 Aug 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

02 Aug 2023 08:00:01 By Nasdaq GlobeNewswire